Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study

The Lancet Publishing Group
Publication Type:
Journal Article
Lancet, 2007, 369 (9555), pp. 37 - 42
Issue Date:
Full metadata record
Files in This Item:
Filename Description SizeFormat
2006011407.pdf194.36 kBAdobe PDF
Background Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the disorder thought most to justify neonatal screening by tandem-mass spectrometry because, without screening, there seems to be substantial morbidity and mortality. Our aim was to asse
Please use this identifier to cite or link to this item: